1. Introduction {#sec1-molecules-25-01405}
===============

Octocorals of the genus *Briareum* (family Briareidae) \[[@B1-molecules-25-01405],[@B2-molecules-25-01405],[@B3-molecules-25-01405],[@B4-molecules-25-01405]\] are proven to be the most important source to produce briarane-type diterpenoids \[[@B5-molecules-25-01405]\]. The compounds of this type are only found in marine invertebrates, particularly in octocorals and demonstrated a wide spectrum of bioactivities, such as anti-inflammatory activity \[[@B6-molecules-25-01405]\] and cytotoxicity \[[@B7-molecules-25-01405]\]. In our continuing research into the chemical constituents of an octocoral *B. excavatum* (Nutting 1911), which was distributed extensively in the coral reefs of Taiwan, have resulted in isolation of three previously unreported 8,17-epoxybriaranes--briarenols I--K (**1**--**3**) along with two known analogues, briaexcavatolide P (**4**) \[[@B8-molecules-25-01405]\] and briaexcavatin P (**5**) \[[@B9-molecules-25-01405]\], ([Figure 1](#molecules-25-01405-f001){ref-type="fig"}). In the current study, the comprehensive workflow of isolation, structure determination, and anti-inflammatory activity evaluation, was implemented on briaranes **1**--**5**.

2. Results and Discussion {#sec2-molecules-25-01405}
=========================

Briarenol I (**1**) was isolated as an amorphous powder and displayed a sodiated adduct ion at *m*/*z* 649.24677 in the (+)-HRESIMS, which indicated its molecular formula was C~30~H~42~O~14~ (calculated for C~30~H~42~O~14~ + Na, 649.24668; unsaturation degrees = 10). The IR spectrum revealed absorptions for hydroxy (ν~max~ 3524 cm^--1^), γ-lactone (ν~max~ 1783 cm^--1^), and ester carbonyl (ν~max~ 1736 cm^--1^) moieties. Resonances in the ^13^C NMR of **1** at δ~C~ 172.9, 172.3, 170.5, 170.0, and 170.0 (5 × C) supported the presence of a γ-lactone and four esters ([Table 1](#molecules-25-01405-t001){ref-type="table"}). Three of the esters were identified as acetates by the presence of three methyl singlet resonances in the ^1^H NMR spectrum at δ~H~ 2.34, 2.15, and 2.08 ([Table 2](#molecules-25-01405-t002){ref-type="table"}) and the remaining ester was found to be an *n*-butyroxy group based on ^1^H NMR studies, including a correlation spectroscopy (COSY) experiment, which revealed seven contiguous protons (δ~H~ 2.30, 2H, t, *J* = 7.2 Hz; 1.63, 2H, tq, *J* = 7.2 Hz; 0.95, 3H, t, *J* = 7.2 Hz). From the COSY spectrum ([Figure 2](#molecules-25-01405-f002){ref-type="fig"}), the proton sequences from H-6/H-7, H-9/H-10/H-11/H-12/H~2~-13/H-14, and H-11/H~3~-20 were established. The hydroxy proton signals at δ~H~ 4.30 (1H, d, *J* = 12.0 Hz), 1.49 (1H, d, *J* = 4.0 Hz), and 3.49 (1H, dd, *J* = 9.6, 4.4 Hz) were found to correlate with H-3 (δ~H~ 4.59, d, *J* = 12.0 Hz), H-12 (δ~H~ 4.10, m), and H~2~-16 (δ~H~ 4.35, 1H, dd, *J* = 13.6, 4.4 Hz; 4.04, 1H, dd, *J* = 13.6, 9.6 Hz), respectively. Thus, the hydroxy groups should be positioned at C-3, C-12, and C-16, respectively. Olefinic resonances in the ^13^C NMR at δ~C~ 125.5 (CH-6) and 142.0 (C-5) indicated the presence of a trisubstituted carbon--carbon double bond. On the basis of these data and the heteronuclear multiple bond correlation (HMBC) experiment ([Figure 2](#molecules-25-01405-f002){ref-type="fig"}), the connectivity from C-1 to C-14 was established. A hydroxymethyl group at C-5 was revealed by the HMBC between C-16 oxymethylene protons to C-4, C-5, and C-6. The C-15 methyl group at C-1 was confirmed by the HMBC between H~3~-15/C-1, C-2, C-10, C-14, and H-10/C-15. The *n*-butyrate positioned at C-4 was confirmed from the connectivity between H-4 (δ~H~ 6.14) and the carbonyl carbon of *n*-butyrate group (δ~C~ 172.3). HMBC from the oxymethine protons at δ~H~ 4.53 (H-2), 5.32 (H-9), and 4.88 (H-14) to the acetate carbonyls at δ~C~ 172.9, 170.0, and 170.0, placed the acetoxy groups on C-2, C-9, and C-14, respectively. Thirteen of the fourteen oxygen atoms in the molecular formula of 1 could be accounted for from the presence of a γ-lactone, four esters, and three hydroxy groups. The remaining oxygen atom had to be placed between C-8 and C-17 to form a tetrasubstituted epoxide based on the ^13^C NMR evidences at δ~C~ 70.8 (C-8) and 62.5 (C-17) and the ^1^H NMR chemical shift of a tertiary methyl at δ~H~ 1.66 (3H, s, H~3~-18).

The stereochemistry of **1** was deduced from an NOESY experiment ([Figure 2](#molecules-25-01405-f002){ref-type="fig"}) and biogenetic considerations. The NOE correlations of H-10/H-11, H-10/H-12, and H-11/H-12 indicated that these protons were situated on the same face of the structure and were assigned as the α protons since the C-15 methyl is the β-substituent at C-1. The NOE correlation between H~3~-15 and H-14 implied that H-14 had a β-orientation. H-3 exhibited a correlation with H-10, and, as well as a lack of coupling constants were detected between H-2/H-3 and H-3/H-4, indicating the dihedral angles between H-2/H-3 and H-3/H-4 were approximately 90° and the 2-acetoxy, 3-hydroxy, and 4-*n*-butyroxy groups were β-, β-, and α-oriented, respectively. A correlation from H-4 to H-7, suggested that H-7 was β-oriented. The *Z*-configuration of C-5/6 double bond was confirmed based on the fact that the C-6 olefinic proton (δ~H~ 5.53) correlated to one of the C-16 hydroxymethyl protons (δ~H~ 4.04). H-9 was found to correlate with H-11, H~3~-18, and H~3~-20. From a consideration of molecular model, H-9 was found to be reasonably close to H-11, H~3~-18, and H~3~-20, thus, H-9 should be placed on the α face, and Me-18 was β-oriented in the γ-lactone moiety, and the 8,17-epoxy group should be α-oriented. It was found that the NMR signals of **1** were similar to those of a known briarane, briaexcavatolide P (**4**) ([Figure 1](#molecules-25-01405-f001){ref-type="fig"}) \[[@B8-molecules-25-01405]\], except that the signals corresponding to the Me-16 vinyl methyl in **4** were replaced by signals for a hydroxymethyl group in **1**. Additionally, as briaranes **1**--**5** were isolated along with a known briarane, excavatolide B (**6**) \[[@B6-molecules-25-01405],[@B10-molecules-25-01405],[@B11-molecules-25-01405]\] from the same target organism, *B. excavatum*, and the absolute configuration of **6** was determined by a single-crystal X-ray diffraction analysis \[[@B6-molecules-25-01405],[@B11-molecules-25-01405]\]. Therefore, on biogenetic grounds to assume that briaranes **1**--**5** had the same absolute stereochemistry as that of **6**, tentatively, and the configurations of stereogenic carbons of **1** were determined as 1*R*,2*R*,3*S*,4*R*,7*S*,8*S*, 9*S*,10*S*,11*R*,12*S*,14*S*, and 17*R* ([Supplementary Materials, Figures S1--S10](#app1-molecules-25-01405){ref-type="app"}).

Briarenol J (**2**) had a molecular formula C~26~H~36~O~12~ by its (+)-HRESIMS at *m*/*z* 563.21007 (calculated for C~26~H~36~O~12~ + Na, 563.20990). The IR spectrum showed bands at 3483, 1779, and 1727 cm^−1^, consistent with the presence of hydroxy, γ-lactone, and ester groups, respectively, in **2**. From the ^13^C and DEPT data ([Table 2](#molecules-25-01405-t002){ref-type="table"}), one trisubstituted double bond was deduced from the signals of two carbons at δ~C~ 139.3 (C-5) and 124.3 (CH-6). A methyl-containing tetrasubstituted epoxy group was confirmed from the signals of two oxygenated quaternary carbons at δ~C~ 69.9 (C-8) and 61.8 (C-17), and from the chemical shift of a tertiary methyl (δ~H~ 1.66, 3H, s; δ~C~ 10.3, CH~3~-18; [Table 1](#molecules-25-01405-t001){ref-type="table"} and [Table 2](#molecules-25-01405-t002){ref-type="table"}). Four carbonyl resonances at δ~C~ 170.9, 170.0, 169.5, and 169.2 in the ^13^C spectrum confirmed the presence of a γ-lactone and three esters. All the esters were identified as acetates by the presence of three methyl singlet resonances in the ^1^H NMR spectrum at δ~H~ 2.32, 2.16, and 2.14, respectively.

Coupling constants information in the COSY spectrum of **2** enabled identification of H-6/H-7, H-9/H-10/H-11/H-12/H~2~-13/H-14, H-11/H~3~-20, and H-6/H~3~-16 (by allylic coupling; [Figure 3](#molecules-25-01405-f003){ref-type="fig"}), these data, together with the HMBC experiment ([Figure 3](#molecules-25-01405-f003){ref-type="fig"}), the molecular framework of **2** could be established. The HMBC also indicated that the acetoxy groups should be attached at C-4, C-9, and C-14, respectively. Thus, the remaining hydroxy groups have to be positioned at C-2, C-3, and C-12, as indicated by the COSY correlations between H-2/OH-2, H-3/OH-3, and H-12/OH-12.

The stereochemistry of **2** was elucidated from the NOE interactions observed in a NOESY experiment ([Figure 3](#molecules-25-01405-f003){ref-type="fig"}) and by the vicinal ^1^H−^1^H coupling constant analysis. In the NOESY spectrum, correlations were observed between H-10 with H-3 and H-12; and H-12 correlated with H-11, indicating that these protons should be α-oriented. H-14 gave a correlation with H~3~-15, confirming the β-orientation for this proton. H-2 showed a correlation with H-14, and a lack of coupling constant was detected between H-2/H-3, indicating the dihedral angle between H-2/H-3 is approximately 90° and the 2-hydroxy group was β-oriented. H-4 exhibited correlations with H-7 and 2-hydroxy proton, confirming the β-orientations for H-4 and H-7. H-9 was found to show correlations with H-11, H~3~-18, and H~3~-20, and from molecular models, H-9 and H~3~-18 should be placed on the α- and β-face, respectively. The *Z*-configuration of C-5/C-6 double bond was elucidated by a correlation between H-6 and H~3~-16. The NMR data of **2** were found to be similar to those of a known briarane, briaexcavatin P (**5**) \[[@B9-molecules-25-01405]\]. It was found that the 2-acetoxy substituent in **5** was replaced by a hydroxy group in **2**. By comparison of the proton and carbon chemical shifts, coupling constants, NOESY correlations, and rotation value of **2** with those of **5**, the stereochemistry of **2** was confirmed to be the same as that of **5**, and the configurations of the stereogenic centers of **2** were assigned as 1*S*,2*R*,3*R*,4*R*, 7*S*,8*S*,9*S*,10*S*,11*R*,12*S*,14*S*, and 17*R* ([Supplementary Materials, Figures S11--S20](#app1-molecules-25-01405){ref-type="app"}).

Briarane **3** (briarenol K) was found to have a molecular formula of C~26~H~36~O~11~ based on its (+)-HRESIMS peak at *m*/*z* 547.21514 (calculated for C~26~H~36~O~11~ + Na, 547.21498). Its absorption peaks in the IR spectrum showed ester carbonyl, γ-lactone, and broad OH stretching at 1739, 1780, and 3468 cm^−1^, respectively. The ^13^C NMR spectrum indicated that three esters and a γ-lactone were present, as carbonyl resonances were observed at δ~C~ 168.1, 170.2, 170.4, and 170.4, respectively ([Table 1](#molecules-25-01405-t001){ref-type="table"}). The ^1^H NMR data also indicated that presence of three acetate methyls at δ~H~ 2.22, 2.03, and 2.00 (each 3H × s; [Table 2](#molecules-25-01405-t002){ref-type="table"}). It was found that the spectroscopic data of **3** were similar to those of a known briarane, briareolide B (**7**) \[[@B12-molecules-25-01405]\]; however, by comparison of the ^1^H and ^13^C NMR chemical shifts of CH-12 oxymethine (δ~H~ 3.72, 1H, dd, *J* = 12.4, 4.8 Hz; δ~C~ 73.4), CH~2~-13 sp^3^ methylene (δ~H~ 1.67, 1H, m; 2.04, 1H, m; δ~C~ 30.2), C-11 oxygenated quaternary carbon (δ~C~ 78.2), and Me-20 tertiary methyl (δ~H~ 1.15, 3H, s; δ~C~ 16.9) of **3** with those of **7** (δ~H~ 3.56, 1H, m; δ~C~ 73.9, CH-12; δ~H~ 2.03, 1H, m; 2.12, 1H, m; δ~C~ 27.6, CH~2~-13; δ~C~ 74.7, C-11; δ~H~ 1.16, 3H, s; δ~C~ 22.5, Me-20) \[[@B12-molecules-25-01405]\] showed that the hydroxy group at C-12 in **3** was β-oriented. The locations of the functional groups were further confirmed by other HMBC and COSY correlations ([Figure 4](#molecules-25-01405-f004){ref-type="fig"}), and hence briarenol K was assigned the structure of **3**. The NOESY spectrum exhibited a correlation from H-10 to H-12, further supporting that H-12 was α-oriented and the stereogenic centers of **3** were assigned as 1*S*,2*S*,7*S*,8*S*,9*S*,10*S*,11*S*,12*S*,14*S*, and 17*R*, by the correlations observed in a NOESY spectrum ([Figure 4](#molecules-25-01405-f004){ref-type="fig"}) and this compound was found to be the 12-epimer of briareolide B (**7**) \[[@B12-molecules-25-01405]\] ([Supplementary Materials, Figures S21--S30](#app1-molecules-25-01405){ref-type="app"}).

The inhibition effects of briaranes **1**--**5** on the release of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) protein from lipopolysaccharides (LPS)-stimulated RAW 264.7 were assessed. The results showed that briarane **4** reduced the release of iNOS and COX-2 to 35.37% and 54.61% at a concentration of 10 µM, respectively ([Figure 5](#molecules-25-01405-f005){ref-type="fig"} and [Table 3](#molecules-25-01405-t003){ref-type="table"}). Briarane **1** was found to be weaker than those of **4** in term of reducing the expression of iNOS and COX-2, indicating that the hydroxy group at C-16 in **1** reduced the activity.

3. Materials and Methods {#sec3-molecules-25-01405}
========================

3.1. General Experimental Procedures {#sec3dot1-molecules-25-01405}
------------------------------------

Optical rotation values were measured using a Jasco P-1010 digital polarimeter (Japan Spectroscopic, Tokyo, Japan). IR spectra were measured on a Thermo Scientific Nicolet iS5 FT-IR spectrophotometer (Waltham, MA, USA). NMR spectra were taken on a Jeol Resonance ECZ 400 S NMR spectrometer (Tokyo, Japan), using the residual CHCl~3~ signal (δ~H~ 7.26 ppm) and CDCl~3~ (δ~C~ 77.1 ppm) as the internal standard for ^1^H and ^13^C NMR, respectively; coupling constants (*J*) are presented in Hz. ESIMS and HRESIMS were recorded using a Bruker 7 Tesla solariX FTMS system. Column chromatography was carried out with silica gel (230--400 mesh, Merck, Darmstadt, Germany). TLC was performed on plates precoated with Kieselgel 60 F~254~ (0.25-mm-thick, Merck, Darmstadt, Germany), then sprayed with 10% H~2~SO~4~ solution followed by heating to visualize the spots. Normal-phase HPLC (NP-HPLC) was performed using a system comprised of a Hitachi L-7100 pump (Tokyo, Japan) and a Rheodyne 7725i injection port (Rohnert Park, CA, USA). Reverse-phase HPLC (RP-HPLC) was performed using a system comprised of a Hitachi L-2130 pump (Tokyo, Japan), a Hitachi L-2455 photodiode array detector (Tokyo, Japan), and a Rheodyne 7725i injection port (Rohnert Park, CA, USA). A semipreparative normal-phase column (YMC-Pack SIL, S-5 µm, 250 mm × 20 mm, Sigma-Aldrich, St. Louis, MO, USA) was used for NP-HPLC. A semipreparative reverse-phase column (Luna, 5 µm, C18(2) 100 Å, AXIA Packed, 250 mm × 21.2 mm; Phenomenex, Torrance, CA, USA) was used for RP-HPLC.

3.2. Animal Material {#sec3dot2-molecules-25-01405}
--------------------

Specimens of *B. excavatum* were collected in June 2017 by hand with self-contained underwater breathing apparatus (SCUBA*)* divers off the coast of Lanyu Island (Orchid Island), Taiwan. The samples were then stored in a --20 °C freezer until extraction. A voucher specimen was deposited in the National Museum of Marine Biology and Aquarium, Taiwan (NMMBA-TW-SC-2017-418). Identification of the species of this organism was performed by comparison as described in previous publications \[[@B1-molecules-25-01405],[@B2-molecules-25-01405],[@B3-molecules-25-01405],[@B4-molecules-25-01405]\].

3.3. Extraction and Isolation {#sec3dot3-molecules-25-01405}
-----------------------------

The freeze-dried and sliced bodies (wet/dry weight = 1344/568 g) of the specimen were extracted with supercritical CO~2~ to give 58.9 g of extract. Partial extract (36.4 g) was then applied on silica gel column and eluted with gradients of *n*-hexane/EtOAc to furnish fractions A−K. Fraction F was purified by NP-HPLC using a mixture of *n*-hexane/acetone (4:1) to yield fractions F1−F13. Fraction F6 was repurified by RP-HPLC, using a mixture of MeOH/H~2~O (60:40; at a flow rate = 4 mL/min) to afford **4** (6.7 mg). Fraction G was separated by NP-HPLC, using a mixture of *n*-hexane/acetone (3:1) to yield fractions G1−G12. Fractions G6 and G7 were repurified by RP-HPLC using a mixture of MeOH/H~2~O (60:40; at a flow rate = 4.0 mL/min) to afford **5** (1.3 mg) and **3** (1.0 mg), respectively. Fraction H was separated by NP-HPLC using a mixture of *n*-hexane and acetone (3:1) to yield fractions H1−H18. Fractions H12 and H15 were repurified by RP-HPLC, using a mixture of MeOH/ H~2~O (60:40; at a flow rate = 4.0 mL/min) to afford **2** (2.1 mg) and **1** (0.6 mg), respectively.

Briarenol I (**1**): Amorphous powder; ${\lbrack\alpha\rbrack}_{D}^{22}$ + 207 (*c* 0.03, CHCl~3~), IR (ATR) ν~max~ 3524, 1783, 1736, 1222, 891 cm^−1^; ^13^C (100 MHz, CDCl~3~) and ^1^H (400 MHz, CDCl~3~) NMR data (see [Table 1](#molecules-25-01405-t001){ref-type="table"} and [Table 2](#molecules-25-01405-t002){ref-type="table"}); ESIMS: *m*/*z* 649 \[M + Na\]^+^; HRESIMS *m*/*z* 649.24677 (calculated for C~30~H~42~O~14~ + Na, 649.24668).

Briarenol J (**2**): Amorphous powder; ${\lbrack\alpha\rbrack}_{D}^{26}$ + 140 (*c* 0.08, CHCl~3~), IR (ATR) ν~max~ 3483, 1779, 1727, 1220, 890 cm^−1^; ^13^C (100 MHz, CDCl~3~) and ^1^H (400 MHz, CDCl~3~) NMR data (see [Table 1](#molecules-25-01405-t001){ref-type="table"} and [Table 2](#molecules-25-01405-t002){ref-type="table"}); ESIMS: *m*/*z* 563 \[M + Na\]^+^; HRESIMS *m*/*z* 563.21007 (calculated for C~26~H~36~O~12~ + Na, 563.20990).

Briarenol K (**3**): Amorphous powder; ${\lbrack\alpha\rbrack}_{D}^{23}$ + 37 (*c* 0.06, CHCl~3~), IR (ATR) ν~max~ 3468, 1780, 1739, 1255, 892 cm^−1^; ^13^C (100 MHz, CDCl~3~) and ^1^H (400 MHz, CDCl~3~) NMR data (see [Table 1](#molecules-25-01405-t001){ref-type="table"} and [Table 2](#molecules-25-01405-t002){ref-type="table"}); ESIMS: *m*/*z* 547 \[M + Na\]^+^; HRESIMS *m*/*z* 547.21514 (calculated for C~26~H~36~O~11~ + Na, 547.21498).

Briaexcavatolide P (**4**): Amorphous powder; ${\lbrack\alpha\rbrack}_{D}^{24}$ + 182 (*c* 0.3, CHCl~3~) (ref. \[[@B8-molecules-25-01405]\], \[α\]27D + 167 (*c* 1.0, CHCl~3~)), IR (ATR) ν~max~ 3513, 1783, 1731, 1218, 889 cm^−1^; ^1^H and ^13^C NMR data were found to be in agreement with previous study \[[@B8-molecules-25-01405]\]; ESIMS: *m*/*z* 633 \[M + Na\]^+^.

Briaexcavatin P (**5**): Amorphous powder; ${\lbrack\alpha\rbrack}_{D}^{23}$ + 134 (*c* 0.05, CHCl~3~) (ref. \[[@B9-molecules-25-01405]\], ${\lbrack\alpha\rbrack}_{D}^{25}$ + 198 (*c* 0.08, CHCl~3~)), IR (ATR) ν~max~ 3503, 1785, 1735, 1240, 889 cm^−1^; ^1^H and ^13^C NMR data were found to be in agreement with previous study \[[@B9-molecules-25-01405]\]; ESIMS: *m*/*z* 605 \[M + Na\]^+^.

3.4. In Vitro Anti-inflammatory Assay {#sec3dot4-molecules-25-01405}
-------------------------------------

The proinflammatory suppression assay was employed to assess the activities of the isolated compounds **1**--**5** against the release of iNOS and COX-2 from macrophage cells as the literature reported \[[@B13-molecules-25-01405],[@B14-molecules-25-01405],[@B15-molecules-25-01405]\].

4. Conclusions {#sec4-molecules-25-01405}
==============

*B. excavatum* was demonstrated to have a wide structural diversity of briarane-type diterpenoids that possessed various pharmacological properties, especially in anti-inflammatory activity. In our continued study on *B. excavatum*, three previously unreported briaranes, briarenols I--K (**1**--**3**), along with the known analogues, briaexcavatolide P (**4**) and briaexcavatin P (**5**), were isolated. In the present study, the anti-inflammatory activity of **1**--**5** was assessed using inhibition of pro-inflammatory iNOS and COX-2 release from macrophages. The results indicated that briaexcavatolide P (**4**) showed the most potent suppressive effect on iNOS release.

The Supplementary Materials are available online. ESIMS, HRESIMS, IR, 1D and 2D NMR spectra of new compounds **1**--**3**.
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Click here for additional data file.
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![Structures of briarenols I--K (**1**--**3**), briaexcavatolide P (**4**), briaexcavatin P (**5**), excavatolide B (**6**), and briareolide B (**7**).](molecules-25-01405-g001){#molecules-25-01405-f001}

![The COSY (![](molecules-25-01405-i001.jpg)) correlations, selective HMBC (![](molecules-25-01405-i002.jpg)), and protons with key NOESY correlations (![](molecules-25-01405-i003.jpg)) of **1**.](molecules-25-01405-g002){#molecules-25-01405-f002}

![The COSY (![](molecules-25-01405-i001.jpg)) correlations, selective HMBC (![](molecules-25-01405-i002.jpg)), and protons with key NOESY correlations (![](molecules-25-01405-i003.jpg)) of **2**.](molecules-25-01405-g003){#molecules-25-01405-f003}

![The COSY (![](molecules-25-01405-i001.jpg)) correlations, selective HMBC (![](molecules-25-01405-i002.jpg)), and protons with key NOESY correlations (![](molecules-25-01405-i003.jpg)) of **3**.](molecules-25-01405-g004){#molecules-25-01405-f004}

![Western blotting showed that briarane **4** downregulated the expression of iNOS and COX-2. Data were normalized to the cells treated with LPS only, and cells treated with dexamethasone (Dex; 10 µM) were used as a positive control. Data are expressed as the mean ± SEM (*n* = 2\~4). \* Significantly different from cells treated with LPS (*p* \< 0.05).](molecules-25-01405-g005){#molecules-25-01405-f005}
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###### 

^13^C NMR (δ~C~ 100 MHz, CDCl~3~) data for briaranes **1**--**3**.

  Position        1             2             3
  --------------- ------------- ------------- -------------
  1               43.3, C ^a^   43.7, C       47.7, C
  2               87.4, CH      85.6, CH      74.9, CH
  3               73.1, CH      73.6, CH      31.6, CH~2~
  4               66.0, CH      65.9, CH      28.4, CH~2~
  5               142.0, C      139.3, C      144.8, C
  6               125.5, CH     124.3, CH     118.4, CH
  7               74.1, CH      74.0, CH      74.9, CH
  8               70.8, C       69.9, C       70.8, C
  9               66.2, CH      67.1, CH      67.4, CH
  10              40.5, CH      41.4, CH      49.0, CH
  11              37.2, CH      36.4, CH      78.2, C
  12              66.6, CH      67.0, CH      73.4, CH
  13              30.2, CH~2~   30.4, CH~2~   30.2, CH~2~
  14              80.5, CH      80.1, CH      74.8, CH
  15              18.6, CH~3~   19.1, CH~3~   14.3, CH~3~
  16              62.5, CH~2~   16.8, CH~3~   27.2, CH~3~
  17              62.5, C       61.8, C       66.5, C
  18              10.3, CH~3~   10.3, CH~3~   10.4, CH~3~
  19              170.5, C      170.9, C      170.4, C
  20              8.9, CH~3~    8.7, CH~3~    16.9, CH~3~
  OAc-2           172.9, C                    170.2, C
                  21.2, CH~3~                 21.2, CH~3~
  OAc-4                         169.5, C      
                                21.0, CH~3~   
  OAc-9           170.0, C      169.2, C      168.1, C
                  21.5, CH~3~   21.1, CH~3~   21.5, CH~3~
  OAc-14          170.0, C      170.0, C      170.4, C
                  21.2, CH~3~   21.0, CH~3~   21.3, CH~3~
  *n*-OC(O)Pr-4   172.3, C                    
                  35.9, CH~2~                 
                  18.2, CH~2~                 
                  13.7, CH~3~                 

^a^ Multiplicity deduced by DEPT and HSQC spectra.

molecules-25-01405-t002_Table 2

###### 

^1^H NMR (δ~H~, 400 MHz in CDCl~3~) data (*J* in Hz) for briaranes **1**--**3**.

  Position        1                                          2                    3
  --------------- ------------------------------------------ -------------------- ------------------------------------
  2               4.53 s                                     3.45 d (10.4)        5.13 d (8.4)
  3α/β            4.59 d (12.0)                              4.27 d (10.4)        1.67 m; 2.60 ddd (16.0, 14.8, 6.0)
  4/4′            6.14 s                                     6.05 d (1.2)         2.48 br d (16.0); 1.90 m
  6               5.53 d (6.0)                               5.29 dq (6.4, 1.6)   5.19 s
  7               5.62 d (6.0)                               5.71 d (6.4)         5.19 s
  9               5.32 d (8.8)                               5.26 d (9.2)         5.78 d (1.2)
  10              2.64 dd (8.8, 4.8)                         2.55 dd (9.2, 5.2)   2.14 br s
  11              2.41 m                                     2.47 m               
  12              4.10 m                                     4.05 m               3.72 dd (12.4, 4.8)
  13α/β           1.75 m; 2.01 m                             1.69 m; 2.00 m       1.67 m; 2.04 m
  14              4.88 dd (2.8, 2.8)                         4.92 dd (2.8, 2.8)   4.79 dd (2.4, 2.0)
  15              0.99 s                                     0.99 br s            1.21 s
  16a/b           4.35 dd (13.6, 4.4); 4.04 dd (13.6, 9.6)   1.89 br s            1.99 s
  18              1.66 s                                     1.66 s               1.77 s
  20              1.12 d (6.8)                               1.07 d (7.2)         1.15 s
  OH-2                                                       2.79 d (10.4)        
  OH-3            4.30 d (12.0)                              2.87 d (10.4)        
  OH-12           1.49 d (4.0)                               1.43 d (4.0)         \-
  OH-16           3.49 dd (9.6, 4.4)                                              
  OAc-2           2.08 s                                                          2.00 s
  OAc-4                                                      2.14 s               
  OAc-9           2.34 s                                     2.32 s               2.22 s
  OAc-14          2.15 s                                     2.16 s               2.03 s
  *n*-OC(O)Pr-4   0.95 t (7.2)                                                    
                  1.63 tq (7.2)                                                   
                  2.30 t (7.2)                                                    
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###### 

Effects of briaranes **1**--**5** on LPS-induced pro-inflammatory iNOS and COX-2 protein expression in macrophages.

                     iNOS            COX-2           β-Actin         
  ------------------ --------------- --------------- --------------- ---
  Negative Control   1.71 ± 0.13     0.62 ± 0.09     120.48 ± 1.28   2
  LPS                100.00 ± 4.53   100.00 ± 6.05   100.00 ± 3.09   4
  1                  60.27 ± 7.05    80.63 ± 2.32    100.29 ± 2.46   4
  2                  60.94 ± 4.89    79.65 ± 4.27    98.29 ± 3.35    4
  3                  66.64 ± 4.79    97.28 ± 5.66    100.49 ± 6.44   4
  4                  35.37 ± 4.94    54.61 ± 4.03    104.56 ± 2.83   4
  5                  62.36 ± 5.42    72.63 ± 2.6     104.79 ± 2.76   4
  Dexamethasone      41.00 ± 2.63    3.73 ± 0.35     104.24 ± 5.82   2

Data were normalized to those of cells treated with LPS alone, and cells treated with dexamethasone were used as a positive control. Data are expressed as the mean ± SEM (*n* = 2--4).
